$AIRS Cashflow Statement | Understand Stock

$AIRS

$1.17 -$0.03 (2.5%) Close

$AIRS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Equity-based compensation
Non-cash interest expense; amortization of debt costs
Loss on debt modification
Deferred income taxes
Loss on impairment of long-lived assets
Cost related to closing location
Changes in assets and liabilities
Taxes receivable
Prepaid expense and other current assets
Other assets
Accounts payable
Deferred revenue and patient deposits
Accrued and other liabilities
Net cash used in operating activities
Cash flows from investing activities
Purchases of property and equipment, net
Net cash used in investing activities
Cash flows from financing activities
Payments on term loan
Borrowings on term loan, net
Proceeds from IPO
Payments for debt modification
Payments on revolving credit facility
Proceeds from public offerings, net
Distribution to member
Dividends paid to shareholders
Payment of taxes withheld through vested equity-based compensation
Other financing activity
Net cash used in financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents
Beginning of period
End of period
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash investing information:
Property and equipment included in accounts payable and accrued expenses
Distributions to member included in accrued expenses

Comments